# Hillspire

> Hillspire is a VC fund in Menlo Park backing Biotechnology and EdTech. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Menlo Park, United States
- Total investments: 5
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/hillspire-llc/about/
- Website: https://www.hillspirellc.com

Hillspire is an integrated family office management company serving all the activities of Eric and Wendy Schmidt, including The Schmidt Family Foundation, the Schmidt Ocean Institute, and Schmidt Futures, and supporting 350+ employees worldwide.

## Contacts

5 contacts available for Hillspire. Shizune tracks 3 team members at Hillspire. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hillspire?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| EdTech | 1 | 20% |
| Energy | 1 | 20% |
| Mobile | 1 | 20% |
| Software | 1 | 20% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Grant | 1 | 20% |
| Series B | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Gregg Goldman | Chief Financial Officer and Senior Vice President, Finance | 0 | https://shizune.co/investors/profile/gregg-goldman |
| Kenneth Goldman | President | 8 | https://shizune.co/investors/profile/kenneth-goldman |
| Ken Goldman | President & Co-founder | 0 | https://shizune.co/investors/profile/ken-goldman-6 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| General Intuition | General Intuition is a frontier research lab focused on teaching machines to learn and adapt through play, aiming to build artificial intelligence that can perceive, anticipate, and improvise in real-world dynamics, with gaming as a central domain for testing and innovation. | $320M | Series A | Jun 25, 2026 |  |
| OurWorlds | OurWorlds is an edutainment company creating technologies that empower communities to illuminate their narratives in immersive realities by geolocation in environments throughout the world, in order to inspire transformative new understandings of our collective histories; improve our education system; inform new approaches to environmentalstewardship; and reframe a more equitable and just future. |  | Grant | Sep 20, 2024 |  |
| Tierra Biosciences | Tierra Biosciences is a synthetic biology company that accelerates the pace of discovery and enables the next generation of bio-based materials. Tierra’s first product, the Tierra Protein Platform, couples high-throughput protein manufacturing with the simplicity of e-commerce to make ordering custom proteins easier than ever before. By loweringthe traditional protein synthesis barrier, Tierra serves scientists looking to change the world with novel proteins. Led by a team of protein experts, this fast-growing company is transforming the way people discover, screen, and develop proteins for future bio-based products. For more information, visit tierrabiosciences.com. | $11.4M | Series A | Mar 12, 2024 |  |
| Sion Power | Sion Power is the global leader in the development of a new generation of high-energy, rechargeable lithium batteries for portable power, mobile electronics, and electric vehicles. Based on the five times higher energy available from sulfur ions compared to other lithium chemistries, Sion Power's lithium sulfur cell offers significantimprovements in performance over current rechargeable batteries. The use of low cost raw materials and accepted battery manufacturing techniques enable this new technology to have a very, competitive cost position. | $75M | Series A | Jan 23, 2024 |  |
| Antheia | Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole-cell engineering —reconstructing complex molecules in yeast to bring to market next-generation plant-inspired medicines. | $73M | Series B | Jun 30, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 3 deals together
- [Euclidean Capital](https://shizune.co/investors/profile/euclidean-capital) — VC Fund, 2 deals together
- [Material Impact](https://shizune.co/investors/profile/material-impact-fund) — VC Fund, 2 deals together
- [Creative Ventures](https://shizune.co/investors/profile/creative-ventures) — VC Fund, 1 deal together
- [Freeflow Ventures](https://shizune.co/investors/profile/freeflow-ventures) — VC Fund, 1 deal together
- [Hedosophia](https://shizune.co/investors/profile/hedosophia) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Hillspire invest in?

Hillspire invests primarily in Biotechnology, EdTech and Energy startups, most often at Series A and Grant stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Hillspire?

Public channels for Hillspire include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hillspire?

The team at Hillspire includes Gregg Goldman (Chief Financial Officer and Senior Vice President, Finance), Kenneth Goldman (President) and Ken Goldman (President & Co-founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co